Mr Robert J Bell joined the Trust as chief executive in March 2005 from the William Osler Health Centre, Ontario, Canada, where he was president and chief executive officer. He has had over 40 years’ international experience in hospital and health services management. He is a member of the board of directors of Imperial College Health Partners, the Institute of Cardiovascular Medicine and Science and the heart charity CORDA. He has previously held positions as vice president, Health Care and Life Sciences Market Sectors, Cap Gemini, Ernst & Young Canada Inc; partner, Ernst & Young and at KPMG (Peat Marwick), Toronto; vice president, Hilton Universal Hospitals UK Ltd, London; vice president, International Services, Extendicare Inc (London and Toronto); executive director of District Health Councils in the Ministry of Health, Ontario; Treasury Board officer, Management Board of Cabinet, Government of Ontario; and systems engineer, Hospital for Sick Children, Toronto. He is a Bachelor of applied science in industrial engineering and a Master of public administration.
Mr Robert Craig is the Trust's chief operating officer. He joined Harefield Hospital in 1995, having previously worked in community and general hospital services. Following the Trust merger in 1998, he became site director at Harefield and, in 2001, deputy director of operations for the Trust. Robert has also fulfilled the roles of director of governance and quality (2003-2006) and director of planning and strategy (2006-2009) – in the latter post, he was responsible for the Trust’s foundation trust application. He was appointed to his current role in mid-2008.
Professor Timothy Evans BSc MD phD DSc FRCP FRCA FMedSci is medical director of the Trust and was appointed deputy chief executive on 31 March 2006. In addition to his various roles within the Trust (such as director of clinical governance and consultant in intensive care and thoracic medicine), he is professor of intensive care medicine at Imperial College London, head of the unit of critical care at the National Heart and Lung Institute, and honorary consultant in intensive care medicine to HM Forces. He is also vice dean of the faculty of intensive care medicine and academic vice president of the Royal College of Physicians.
Mr Richard Paterson
joined the Trust as interim director of finance in January 2011 for a six-month term. He subsequently rejoined the Trust as associate chief executive - finance and was appointed to the Board on 26 October 2011. He worked at KPMG, accountants and business advisers, for 40 years, appointed to the partnership in 1986 and retiring in 2010. In addition to client responsibilities for listed companies and public interest entities, his management roles included: six years in charge of KPMG UK's infrastructure, government and healthcare division; head of markets for KPMG's Europe, Middle East and Africa region; and executive chair of the global professional indemnity insurance committee, a committee of the international board of KPMG. Mr Paterson continues to provide ad hoc consultancy services to KPMG.
Dr Caroline Shuldham, director of nursing and clinical governance, has worked in the Trust since its inception, having previously been employed at Royal Brompton Hospital. She has a background in cardiac and intensive care nursing, nursing education and research. In addition to leading nursing, she is responsible for clinical governance, and patient and public involvement. Dr Shuldham is an honorary teaching fellow at the National Heart and Lung Institute of Imperial College London, a nurse fellow of the European Society of Cardiology and a member of the editorial board of the British Journal of Cardiac Nursing. Dr Shuldham was recognised with an OBE on the Queen’s Birthday Honours List in June 2009.
Sir Robert Finch was appointed by the Appointments Commission as the Trust’s chair, effective from 1 January 2009 for a three-year term, which was renewed in December 2012, effective until December 2014. Sir Robert brings significant board experience to the Trust, both in the business and not-for-profit sectors. He has a legal background, having qualified as a solicitor in 1969. He spent his career at the City law firm Linklaters, latterly as a head of real estate. He is a former alderman of the City and former Lord Mayor of London (2003-2004) and has been a member of a number of City Corporation committees. In 2005, Sir Robert joined the board of Liberty International plc, a FTSE 100 London-based property company and held this position until July 2008.
Mrs Lesley-Anne Alexander CBE has been chief executive of the Royal National Institute of Blind People (RNIB) since January 2004, prior to which she was director of operations for the Peabody Trust and director of housing for the London Borough of Enfield. She joined Royal Brompton & Harefield NHS Foundation Trust as a non-executive director in February 2013.
Lesley-Anne currently chairs both the UK Vision Strategy Group and ACEVO (the Association of Chief Executives of Voluntary Organisations). She was awarded a CBE in The Queen's 2012 Birthday Honours list in recognition of her services to the voluntary sector.
Mr Richard Hunting is chairman of Hunting PLC, the international oil services company. He is also chairman of CORDA: Charity: preventing heart disease and stroke, a court member of the Ironmongers’ Company, one of the 12 principal livery companies of the City of London; chairman of The Battle of Britain Memorial Trust. He has an engineering degree from Sheffield University and an MBA from Manchester Business School.
Mr Neil Lerner was first appointed to the Trust Board in February 2010, with a three-year reappointment approved in February 2013, effective until January 2016. He is an experienced accountant specialising in all aspects of risk management. He has played a key role in the development of ethical standards for the accountancy profession, globally and in the UK. After becoming partner at leading international provider of professional services, KPMG, in 1984, Mr Lerner held a number of senior positions, including head of privatisations, head of corporate finance and head of transaction services business for KPMG UK, and chairman of the KPMG Global Professional Indemnity Insurance Group. He retired from the firm in 2006 and currently holds a number of non-executive posts.
Ms Kate Owen runs a consulting business advising on change and development in organisations. She retired as vice president executive development at BP in 2005 having worked with the company for 24 years. Her 35-year industry career spanned line management, general HR work, training and organisational transformation. Her previous experience was in retail and the public sector. She spent nine years on the board of HM Revenue and Customs, was chair of the Conference Board (Europe) Organisation and Business Council, a member of the Ministry of Defence Armed Forces Training and Education Steering Group and a member of the UK Government Risk Review Steering Group. Ms Owen is currently a governor of Imperial College, a fellow of the Windsor Leadership Trust and a non-executive director of Bioss International (executive development).
Mr Andrew Vallance-Owen trained as a surgeon in Newcastle upon Tyne but, after holding various positions on the staff of the BMA including head of policy development, became group medical director of Bupa in 1995. Following his retirement from Bupa in 2012, he has taken up a number of non-executive roles; he is chair of the South West Peninsula Academic Health Science Network and the Department of Health’s Patient Reported Outcomes Stakeholder Group. He joined Royal Brompton & Harefield NHS Foundation Trust in February 2013.
He has a strong interest in outcome measurement, clinical audit and greater clinical accountability, and is a passionate advocate of patient feedback in service improvement and shared decision making. Mr Vallance-Owen studied medicine at Birmingham University where he recently received an Honorary Doctorate.
Non-executive director (non-independent)
Professor Kim Fox is consultant cardiologist at the Trust as well as professor of clinical cardiology and head of the National Heart and Lung Institute, Imperial College, London. Professor Fox is chairman at the Institute for Cardiovascular Medicine and Science (in partnership with Liverpool Heart and chest Hospital) and is the Diana Princess of Wales Chair in Cardiovascular Medicine and Science. He was appointed as non-executive director (non-independent) to the Trust Board on 1 June 2013.